As presented in Figure 4, pre-operative AVT was a protective factor of RFS for patients with high or low load of HBV-DNA load, high or low level of AFP, positive HBeAg, tumor size (>5 cm), cirrhosis, MVI, and for those without EGV (all P<0.05). The gene discussed is AFP; the disease is neoplasm.